Cargando…

Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy

Introduction: The absolute BK viral load is an important diagnostic surrogate for BK polyomavirus associated nephropathy (PyVAN) after renal transplant (KTX) and serial assessment of BK viremia is recommended. However, there is no data indicating which particular viral load change, i.e., absolute vs...

Descripción completa

Detalles Bibliográficos
Autores principales: Omić, Haris, Kläger, Johannes Phillip, Herkner, Harald, Aberle, Stephan W., Regele, Heinz, Weseslindtner, Lukas, Schrag, Tarek Arno, Bond, Gregor, Hohenstein, Katharina, Watschinger, Bruno, Werzowa, Johannes, Strassl, Robert, Eder, Michael, Kikić, Željko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770438/
https://www.ncbi.nlm.nih.gov/pubmed/35071271
http://dx.doi.org/10.3389/fmed.2021.791087
_version_ 1784635372217565184
author Omić, Haris
Kläger, Johannes Phillip
Herkner, Harald
Aberle, Stephan W.
Regele, Heinz
Weseslindtner, Lukas
Schrag, Tarek Arno
Bond, Gregor
Hohenstein, Katharina
Watschinger, Bruno
Werzowa, Johannes
Strassl, Robert
Eder, Michael
Kikić, Željko
author_facet Omić, Haris
Kläger, Johannes Phillip
Herkner, Harald
Aberle, Stephan W.
Regele, Heinz
Weseslindtner, Lukas
Schrag, Tarek Arno
Bond, Gregor
Hohenstein, Katharina
Watschinger, Bruno
Werzowa, Johannes
Strassl, Robert
Eder, Michael
Kikić, Željko
author_sort Omić, Haris
collection PubMed
description Introduction: The absolute BK viral load is an important diagnostic surrogate for BK polyomavirus associated nephropathy (PyVAN) after renal transplant (KTX) and serial assessment of BK viremia is recommended. However, there is no data indicating which particular viral load change, i.e., absolute vs. relative viral load changes (copies/ml; percentage of the preceding viremia) is associated with worse renal graft outcomes. Materials and Methods: In this retrospective study of 91 biopsy proven PyVAN, we analyzed the interplay of exposure time, absolute and relative viral load kinetics, baseline risk, and treatment strategies as risk factors for graft loss after 2 years using a multivariable Poisson-model. Results: We compared two major treatment strategies: standardized immunosuppression (IS) reduction (n = 53) and leflunomide (n = 30). The median viral load at the index biopsy was 2.15E+04 copies/ml (interquartile range [IQR] 1.70E+03–1.77E+05) and median peak viremia was 3.6E+04 copies/ml (IQR 2.7E+03–3.3E+05). Treatment strategies and IS-levels were not related to graft loss. After correction for baseline viral load and estimated glomerular filtration rate (eGFR), absolute viral load decrease/unit remained an independent risk factor for graft loss [incidence rate ratios [IRR] = 0.77, (95% CI 0.61–0.96), p = 0.02]. Conclusion: This study provides evidence for the prognostic importance of absolute BK viremia kinetics as a dynamic parameter indicating short-term graft survival independently of other established risk factors.
format Online
Article
Text
id pubmed-8770438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87704382022-01-21 Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy Omić, Haris Kläger, Johannes Phillip Herkner, Harald Aberle, Stephan W. Regele, Heinz Weseslindtner, Lukas Schrag, Tarek Arno Bond, Gregor Hohenstein, Katharina Watschinger, Bruno Werzowa, Johannes Strassl, Robert Eder, Michael Kikić, Željko Front Med (Lausanne) Medicine Introduction: The absolute BK viral load is an important diagnostic surrogate for BK polyomavirus associated nephropathy (PyVAN) after renal transplant (KTX) and serial assessment of BK viremia is recommended. However, there is no data indicating which particular viral load change, i.e., absolute vs. relative viral load changes (copies/ml; percentage of the preceding viremia) is associated with worse renal graft outcomes. Materials and Methods: In this retrospective study of 91 biopsy proven PyVAN, we analyzed the interplay of exposure time, absolute and relative viral load kinetics, baseline risk, and treatment strategies as risk factors for graft loss after 2 years using a multivariable Poisson-model. Results: We compared two major treatment strategies: standardized immunosuppression (IS) reduction (n = 53) and leflunomide (n = 30). The median viral load at the index biopsy was 2.15E+04 copies/ml (interquartile range [IQR] 1.70E+03–1.77E+05) and median peak viremia was 3.6E+04 copies/ml (IQR 2.7E+03–3.3E+05). Treatment strategies and IS-levels were not related to graft loss. After correction for baseline viral load and estimated glomerular filtration rate (eGFR), absolute viral load decrease/unit remained an independent risk factor for graft loss [incidence rate ratios [IRR] = 0.77, (95% CI 0.61–0.96), p = 0.02]. Conclusion: This study provides evidence for the prognostic importance of absolute BK viremia kinetics as a dynamic parameter indicating short-term graft survival independently of other established risk factors. Frontiers Media S.A. 2022-01-06 /pmc/articles/PMC8770438/ /pubmed/35071271 http://dx.doi.org/10.3389/fmed.2021.791087 Text en Copyright © 2022 Omić, Kläger, Herkner, Aberle, Regele, Weseslindtner, Schrag, Bond, Hohenstein, Watschinger, Werzowa, Strassl, Eder and Kikić. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Omić, Haris
Kläger, Johannes Phillip
Herkner, Harald
Aberle, Stephan W.
Regele, Heinz
Weseslindtner, Lukas
Schrag, Tarek Arno
Bond, Gregor
Hohenstein, Katharina
Watschinger, Bruno
Werzowa, Johannes
Strassl, Robert
Eder, Michael
Kikić, Željko
Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
title Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
title_full Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
title_fullStr Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
title_full_unstemmed Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
title_short Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients With Biopsy Proven BK Polyomavirus Associated Nephropathy
title_sort clinical relevance of absolute bk polyoma viral load kinetics in patients with biopsy proven bk polyomavirus associated nephropathy
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770438/
https://www.ncbi.nlm.nih.gov/pubmed/35071271
http://dx.doi.org/10.3389/fmed.2021.791087
work_keys_str_mv AT omicharis clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT klagerjohannesphillip clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT herknerharald clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT aberlestephanw clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT regeleheinz clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT weseslindtnerlukas clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT schragtarekarno clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT bondgregor clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT hohensteinkatharina clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT watschingerbruno clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT werzowajohannes clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT strasslrobert clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT edermichael clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy
AT kikiczeljko clinicalrelevanceofabsolutebkpolyomaviralloadkineticsinpatientswithbiopsyprovenbkpolyomavirusassociatednephropathy